{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:47:35Z","timestamp":1759366055841,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.gastrohep.2020.01.014","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T17:08:31Z","timestamp":1595264911000},"page":"497-505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ustekinumab en enfermedad de Crohn: efectividad y seguridad en pr\u00e1ctica cl\u00ednica"],"prefix":"10.1016","volume":"43","author":[{"given":"Cristina","family":"Salda\u00f1a Due\u00f1as","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Rull\u00e1n Iriarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Elosua Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Rodr\u00edguez Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saioa","family":"Rubio Iturria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d3scar","family":"Nantes Castillejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2020.01.014_bib0100","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.gtc.2017.05.013","article-title":"Ustekinumab and Anti-Interleukin-23 Agents in Crohn's Disease","volume":"46","author":"Deepak","year":"2017","journal-title":"Gastroenterol Clin North Am."},{"key":"10.1016\/j.gastrohep.2020.01.014_bib0105","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.gastrohep.2017.08.006","article-title":"Ustekinumab to treat Crohn's disease","volume":"40","author":"Gisbert","year":"2017","journal-title":"Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2020.01.014_bib0110","unstructured":"Ficha t\u00e9cnica Stelara [consultado 1 Jul 2017]. Disponible en: https:\/\/ec.europa.eu\/health\/documents\/community-register\/2016\/20160715135582\/anx_135582_es.pdf."},{"key":"10.1016\/j.gastrohep.2020.01.014_bib0115","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJMoa1602773","article-title":"Ustekinumab as induction and maintenance therapy for Crohn's disease","volume":"375","author":"Feagan","year":"2016","journal-title":"N Engl J Med."},{"key":"10.1016\/j.gastrohep.2020.01.014_bib0120","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cgh.2015.09.018","article-title":"Subcutaneous ustekinumab provides clinical benefit for two-thirds of patients with crohn's disease refractory to anti-tumor necrosis factor agents","volume":"14","author":"Wils","year":"2016","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"suppl_1","key":"10.1016\/j.gastrohep.2020.01.014_bib0125","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjx002.064","article-title":"DOP027 Long-term efficacy and safety of ustekinumab in refractory Crohn's disease patients: a multicenter retrospective experience","volume":"11","author":"Wils","year":"2017","journal-title":"J Crohn's Colitis."},{"key":"10.1016\/j.gastrohep.2020.01.014_bib0130","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1097\/MIB.0000000000000842","article-title":"Ustekinumab for the treatment of refractory Crohn's Disease: The spanish experience in a large multicentre open-label cohort","volume":"22","author":"Khorrami","year":"2016","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2020.01.014_bib0135","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/apt.14016","article-title":"Clinical, endoscopic and radiographic outcomes with ustekinumab in medically-refractory Crohn's disease: real world experience from a multicentre cohort","volume":"45","author":"Ma","year":"2017","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2020.01.014_bib0140","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.cgh.2017.03.032","article-title":"Association Between Ustekinumab Trough Concentrations and Clinical Biomarker, and Endoscopic Outcomes in Patients With Crohn's Disease","volume":"15","author":"Battat","year":"2017","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2020.01.014_bib0145","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1203572","article-title":"Ustekinumab induction and maintenance therapy in refractory Crohn's disease","volume":"367","author":"Sandborn","year":"2012","journal-title":"N Engl J Med."},{"key":"10.1016\/j.gastrohep.2020.01.014_bib0150","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.gastrohep.2016.02.004","article-title":"Efficacy and effectiveness of biologic therapy in inflammatory bowel disease EFIFECT study","volume":"39","author":"Ginard","year":"2016","journal-title":"Gastroenterol Hepatol."},{"issue":"Supplement_1","key":"10.1016\/j.gastrohep.2020.01.014_bib0155","doi-asserted-by":"crossref","first-page":"S399","DOI":"10.1093\/ecco-jcc\/jjy222.695","article-title":"P571 Effectiveness and safety of Ustekinumab for induction of remission in patients with Crohn's disease: a multi-centre Israeli study","volume":"13","author":"Bar-Gil Shitrit","year":"2019","journal-title":"J Crohn's Colitis."},{"key":"10.1016\/j.gastrohep.2020.01.014_bib0160","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1080\/00365521.2019.1624817","article-title":"P600 Ustekinumab for Crohn's disease: a nationwide real-life observational cohort study from Finland","volume":"54","author":"Eberl","year":"2019","journal-title":"J Crohn's Colitis. Scand J Gastroenterol."},{"issue":"Supplement_1","key":"10.1016\/j.gastrohep.2020.01.014_bib0165","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1093\/ecco-jcc\/jjy222.311","article-title":"P187 Clinical follow-up of patients with Crohn's disease treated with ustekinumab in our hospital","volume":"13","author":"Valdes Delgado","year":"2019","journal-title":"J Crohn's Colitis."},{"key":"10.1016\/j.gastrohep.2020.01.014_bib0170","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/ecco-jcc\/jjz080","article-title":"Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn's Disease Who Failed Biologic Therapies: A National Cohort Study","volume":"13","author":"Liefferinckx","year":"2019","journal-title":"J Crohns Colitis."},{"key":"10.1016\/j.gastrohep.2020.01.014_bib0175","unstructured":"Santoni A, Serrero M, Altwegg R, Desjeux A, Boivineau L. Efficacy and safety of ustekinumab intravenous induction in a cohort of patients with Crohn's disease refractory to anti-tumor necrosis factor agents. United Eur Gastroenterol J. 2018; 6.(Supplement 1)."},{"issue":"Supplement_1","key":"10.1016\/j.gastrohep.2020.01.014_bib0180","doi-asserted-by":"crossref","first-page":"S364","DOI":"10.1093\/ecco-jcc\/jjy222.629","article-title":"P505 Real-world short-term effectiveness of ustekinumab in Crohn's disease: Results from the ENEIDA Registry","volume":"13","author":"Iborra","year":"2019","journal-title":"J Crohn's Colitis."},{"key":"10.1016\/j.gastrohep.2020.01.014_bib0185","doi-asserted-by":"crossref","first-page":"340","DOI":"10.5217\/ir.2019.00012","article-title":"Ustekinumab is effective in biological refractory Crohn's disease patients-regardless of approval study selection criteria","volume":"17","author":"Saman","year":"2019","journal-title":"Intest Res."},{"key":"10.1016\/j.gastrohep.2020.01.014_bib0190","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjy222.627","article-title":"Ustekinumab for Crohn's disease: results of the ICC Registry, a nationwide prospective observational cohort study","author":"Biemans","year":"2019","journal-title":"J Crohns Colitis."}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570520301576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570520301576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:44:24Z","timestamp":1759322664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570520301576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0210570520301576"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2020.01.014","relation":{},"ISSN":["0210-5705"],"issn-type":[{"type":"print","value":"0210-5705"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ustekinumab en enfermedad de Crohn: efectividad y seguridad en pr\u00e1ctica cl\u00ednica","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2020.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}